CoRe SoHO statement on ENVI Committee amendments to SoHO regulation (May 2023)
Brussels, 22 May 2023 Dear Member of the ENVI Committee, We are writing to you on behalf of the Common[…]
EBA Statement on recent vCJD risk assessments and their impact on blood and plasma collection (October 2022)
Recent updates regarding variant Creutzfeldt-Jakob disease risk assessments and impact on blood and plasma collection in Europe The emergence of[…]
EBA Position on the European Commission proposal for a SoHO Regulation (September 2022)
GENERAL POSITION ON THE PROPOSAL OF THE EUROPEAN COMMISSION FOR A REGULATION ON STANDARDS OF QUALITY AND SAFETY FOR SUBSTANCES[…]
CoRe SoHO statement on SoHO Regulation proposal (September 2022)
CoRe SoHO statement welcoming the proposed Regulation on standards of quality and safety for substances of human origin (SoHO) intended[…]
EBA response the European Commission’s proposal for a European Health Data Space – EHDS (July 2022)
Submitted on 26 July 2022 The European Blood Alliance (EBA) welcomes this proposal on the European Health Data Space (EHDS).[…]
EBA answer to European Commission Inception Impact Assessment on HERA (February 2021)
EBA’s answer to EC consultation on the creation of HERA (submitted online, through the EC “have your say” website) The[…]
EBA response to EC Inception Impact Assessment Revision of EU BTC Directives (December 2020)
EBA agrees with the gaps and issues identified in the first part of the IIA and highlights thefollowing: Reliance on[…]